Abstract
Barbaloin (10-β-D-glucopyranosyl-1,8-dihydroxy-3-(hydroxymethyl)-9(10H)-anthracenone) is extracted from the aloe plant and has been reported to have anti-inflammatory, antitumor, antibacterial, and other biological activities. Here, we investigated the effects of barbaloin on cardiac electrophysiology, which has not been reported thus far. Cardiac action potentials (APs) and ionic currents were recorded in isolated rabbit ventricular myocytes using whole-cell patch-clamp technique. Additionally, the antiarrhythmic effect of barbaloin was examined in Langendorff-perfused rabbit hearts. In current-clamp recording, application of barbaloin (100 and 200 μmol/L) dose-dependently reduced the action potential duration (APD) and the maximum depolarization velocity (Vmax), and attenuated APD reverse-rate dependence (RRD) in ventricular myocytes. Furthermore, barbaloin (100 and 200 μmol/L) effectively eliminated ATX II-induced early afterdepolarizations (EADs) and Ca2+-induced delayed afterdepolarizations (DADs) in ventricular myocytes. In voltage-clamp recording, barbaloin (10–200 μmol/L) dose-dependently inhibited L-type calcium current (ICa.L) and peak sodium current (INa.P) with IC50 values of 137.06 and 559.80 μmol/L, respectively. Application of barbaloin (100, 200 μmol/L) decreased ATX II-enhanced late sodium current (INa.L) by 36.6%±3.3% and 71.8%±6.5%, respectively. However, barbaloin up to 800 μmol/L did not affect the inward rectifier potassium current (IK1) or the rapidly activated delayed rectifier potassium current (IKr) in ventricular myocytes. In Langendorff-perfused rabbit hearts, barbaloin (200 μmol/L) significantly inhibited aconitine-induced ventricular arrhythmias. These results demonstrate that barbaloin has potential as an antiarrhythmic drug.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Song XF, Chen XD . Advances in the research of promotion effect of Aloe vera on wound healing and its clinical use. Zhonghua Shao Shang Za Zhi 2016; 32: 634–37.
Eshun K, He Q . Aloe vera: a valuable ingredient for the food, pharmaceutical and cosmetic industries-a review. Crit Rev Food Sci Nutr 2004; 44: 91–6.
Rajkumar V, Verma AK, Patra G, Pradhan S, Biswas S, Chauhan P, et al. Quality and acceptability of meat nuggets with fresh aloe vera gel. Asian-Australas J Anim Sci 2016; 29: 702–8.
Patel DK, Patel K, Tahilyani V . Barbaloin: a concise report of its pharmacological and analytical aspects. Asian Pac J Trop Biomed 2012; 2: 835–8.
Silva MA, Trevisan G, Hoffmeister C, Rossato MF, Boligon AA, Walker CI, et al. Anti-inflammatory and antioxidant effects of Aloe saponaria Haw in a model of UVB-induced paw sunburn in rats. J Photochem Photobiol B 2014; 133: 47–54.
Alves DS, Perez-Fons L, Estepa A, Micol V . Membrane-related effects underlying the biological activity of the anthraquinones emodin and barbaloin. Biochem Pharmacol 2004; 68: 549–61.
Oumer A, Bisrat D, Mazumder A, Asres K . A new antimicrobial anthrone from the leaf latex of Aloe trichosantha. Nat Prod Commun 2014; 9: 949–52.
El-Shemy HA, Aboul-Soud MA, Nassr-Allah AA, Aboul-Enein KM, Kabash A, Yagi A . Antitumor properties and modulation of antioxidant enzymes' activity by Aloe vera leaf active principles isolated via supercritical carbon dioxide extraction. Curr Med Chem 2010; 17: 129–38.
Beppu H, Koike T, Shimpo K, Chihara T, Hoshino M, Ida C, et al. Radical-scavenging effects of Aloe arborescens Miller on prevention of pancreatic islet B-cell destruction in rats. J Ethnopharmacol 2003; 89: 37–45.
Lam RY, Woo AY, Leung PS, Cheng CH . Antioxidant actions of phenolic compounds found in dietary plants on low-density lipoprotein and erythrocytes in vitro. J Am Coll Nutr 2007; 26: 233–42.
Pimentel M, Zimerman A, Chemello D, Giaretta V, Andrades M, Silvello D, et al. Predictors of serious arrhythmic events in patients with nonischemic heart failure. J Int Cardiovasc Electrophysiol 2017; 48: 131–9.
Marsman RF, Tan HL, Bezzina CR . Genetics of sudden cardiac death caused by ventricular arrhythmias. Nat Rev Cardiol 2014; 11: 96–111.
Tanaka H, Matsuyama TA, Takamatsu T . Towards an integrated understanding of cardiac arrhythmogenesis–growing roles of experimental pathology. Pathol Int 2017; 67: 8–16.
Nerbonne JM, Kass RS . Molecular physiology of cardiac repolarization. Physiol Rev 2005; 85: 1205–53.
Shryock JC, Song Y, Rajamani S, Antzelevitch C, Belardinelli L . The arrhythmogenic consequences of increasing late INa in the cardiomyocyte. Cardiovasc Res 2013; 99: 600–11.
Wang C, Wang LL, Zhang C, Cao ZZ, Luo AT, Zhang PH, et al. Tolterodine reduces veratridine-augmented late INa, reverse-INCX and early afterdepolarizations in isolated rabbit ventricular myocytes. Acta Pharmacol Sin 2016; 37: 1432–41.
Ren Z, Ma J, Zhang P, Luo A, Zhang S, Kong L, et al. The effect of ligustrazine on L-type calcium current, calcium transient and contractility in rabbit ventricular myocytes. J Ethnopharmacol 2012; 144: 555–61.
Sun GB, Sun H, Meng XB, Hu J, Zhang Q, Liu B, et al. Aconitine-induced Ca2+ overload causes arrhythmia and triggers apoptosis through p38 MAPK signaling pathway in rats. Toxicol Appl Pharmacol 2014; 279: 8–22.
Zhao Z, Yin Y, Wu H, Jiang M, Lou J, Bai G, et al. Arctigenin, a potential anti-arrhythmic agent, inhibits aconitine-induced arrhythmia by regulating multi-ion channels. Cell Physiol Biochem 2013; 32: 1342–53.
Bai DL, Chen WZ, Bo YX, Dong YL, Kang AL, Sun WK, et al. Discovery of N-(3,5-bis(1-pyrrolidylmethyl)-4-hydroxybenzyl)-4-methoxybenzenesulfamide (sulcardine) as a novel anti-arrhythmic agent. Acta Pharmacol Sin 2012; 33: 1176–86.
Xu T, Wang H, Zhang JY, Zhang Y, Zhang R, Jiang LQ, et al. Effects of mid-myocardial pacing on transmural dispersion of repolarization and arrhythmogenesis. Europace 2012; 14: 1363–8.
Akar FG, Rosenbaum DS . Transmural electrophysiological heterogeneities underlying arrhythmogenesis in heart failure. Circ Res 2003; 93: 638–45.
Milberg P, Fink M, Pott C, Frommeyer G, Biertz J, Osada N, et al. Blockade of ICa suppresses early afterdepolarizations and reduces transmural dispersion of repolarization in a whole heart model of chronic heart failure. Br J Pharmacol 2012; 166: 557–68.
Jones DK, Ruben PC . Proton modulation of cardiac INa: a potential arrhythmogenic trigger. Handb Exp Pharmacol 2014; 221: 169–81.
Tang Q, Ma J, Zhang P, Wan W, Kong L, Wu L . Persistent sodium current and Na+/H+ exchange contributes to the augmentation of the reverse Na+/Ca2+ exchange during hypoxia or acute ischemia in ventricular myocytes. Pflugers Arch 2012; 463: 513–22.
Undrovinas A, Maltsev VA . Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart. Cardiovasc Hematol Agents Med Chem 2008; 6: 348–59.
Ward CA, Giles WR . Ionic mechanism of the effects of hydrogen peroxide in rat ventricular myocytes. J Physiol 1997; 500: 631–42.
Xie LH, Chen F, Karagueuzian HS, Weiss JN . Oxidative-stress-induced afterdepolarizations and calmodulin kinase II signaling. Circ Res 2009; 104: 79–86.
Du YM, Xia CK, Zhao N, Dong Q, Lei M, Xia JH . 18beta-Glycyrrhetinic acid preferentially blocks late Na current generated by DeltaKPQ Nav1.5 channels. Acta Pharmacol Sin 2012; 33: 752–60.
Katra RP, Laurita KR . Cellular mechanism of calcium-mediated triggered activity in the heart. Circ Res 2005; 96: 535–42.
Fedida D, Noble D, Rankin AC, Spindler AJ . The arrhythmogenic transient inward current iTI and related contraction in isolated guinea-pig ventricular myocytes. J Physiol 1987; 392: 523–42.
Santonastasi M, Wehrens XH . Ryanodine receptors as pharmacological targets for heart disease. Acta Pharmacol Sin 2007; 28: 937–44.
Jiang QS, Huang XN, Yang GZ, Jiang XY, Zhou QX . Inhibitory effect of ginsenoside Rb1 on calcineurin signal pathway in cardiomyocyte hypertrophy induced by prostaglandin F2alpha. Acta Pharmacol Sin 2007; 28: 1149–54.
Yin G, Hassan F, Haroun AR, Murphy LL, Crotti L, Schwartz PJ, et al. Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms. J Am Heart Assoc 2014; 3: e000996.
Sedej S, Heinzel FR, Walther S, Dybkova N, Wakula P, Groborz J, et al. Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation. Cardiovasc Res 2010; 87: 50–9.
Rickover O, Zinman T, Kaplan D, Shainberg A . Exogenous nitric oxide triggers classic ischemic preconditioning by preventing intracellular Ca2+ overload in cardiomyocytes. Cell Calcium 2008; 43: 324–33.
Zhang X, Ai X, Nakayama H, Chen B, Harris DM, Tang M, et al. Persistent increases in Ca2+ influx through Cav1.2 shortens action potential and causes Ca2+ overload-induced afterdepolarizations and arrhythmias. Basic Res Cardiol 2016; 111: 4.
Luo AT, Cao ZZ, Xiang Y, Zhang S, Qian CP, Fu C, et al. Ketamine attenuates the Na+-dependent Ca2+ overload in rabbit ventricular myocytes in vitro by inhibiting late Na+ and L-type Ca2+ currents. Acta Pharmacol Sin 2015; 36: 1327–36.
Ma J, Luo A, Wu L, Wan W, Zhang P, Ren Z, et al. Calmodulin kinase II and protein kinase C mediate the effect of increased intracellular calcium to augment late sodium current in rabbit ventricular myocytes. Am J Physiol Cell Physiol 2012; 302: C1141–51.
Amin AS, Tan HL, Wilde AA . Cardiac ion channels in health and disease. Heart Rhythm 2010; 7: 117–26.
Ten Tusscher KH, Hren R, Panfilov AV . Organization of ventricular fibrillation in the human heart. Circ Res 2007; 100: e87–101.
Cubeddu LX . QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs. Am J Ther 2003; 10: 452–7.
Han SN, Jing Y, Yang LL, Zhang Z, Zhang LR . Propofol inhibits hERG K+ channels and enhances the inhibition effects on its mutations in HEK293 cells. Eur J Pharmacol 2016; 791: 168–78.
Osadchii OE . Reduced intrinsic heart rate is associated with reduced arrhythmic susceptibility in guinea-pig heart. Scand Cardiovasc J 2014; 48: 357–67.
Liu Y, Sun HL, Li DL, Wang LY, Gao Y, Wang YP, et al. Choline produces antiarrhythmic actions in animal models by cardiac M3 receptors: improvement of intracellular Ca2+ handling as a common mechanism. Can J Physiol Pharmacol 2008; 86: 860–5.
Acknowledgements
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cao, Zz., Tian, Yj., Hao, J. et al. Barbaloin inhibits ventricular arrhythmias in rabbits by modulating voltage-gated ion channels. Acta Pharmacol Sin 39, 357–370 (2018). https://doi.org/10.1038/aps.2017.93
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2017.93
Keywords
This article is cited by
-
Model Systems for Addressing Mechanism of Arrhythmogenesis in Cardiac Repair
Current Cardiology Reports (2021)
